Paradoxical reduction of fatty streak formation in mice lacking endothelial nitric oxide synthase

Circulation

Volumn 105, Issue 17, 2002, Pages 2078-2082

  Shi, Weibin ^a,c   Wang, Xuping ^c   Shih, Diana M ^c   Laubach, Victor E ^b   Navab, Mohamad ^c   Lusis, Aldons J ^c,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Endothelium; Lipoproteins; Nitric oxide synthase

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DIET; ENDOTHELIUM CELL; FEMALE; LIPID BLOOD LEVEL; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL;

ANIMALS; AORTIC DISEASES; ARTERIOSCLEROSIS; CELLS, CULTURED; DINOPROST; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; F2-ISOPROSTANES; FEMALE; KINETICS; LIPIDS; LIPOPROTEINS, LDL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III;

EID: 0037197714     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000015853.59427.32     Document Type: Article

References (30)

1. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia
2. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP
3. Nitric oxide inhibits angiotensin II-induced migration of rat smooth muscle cell
4. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions
5. Regression of atherosclerosis: Role of nitric oxide and apoptosis
6. Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
7. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit
8. L-Arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice
9. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta: PGH2 does not contribute to impaired endothelium-dependent relaxation
10. The vascular effects of L-arginine in humans: The role of endogenous insulin
11. Superoxide generation from endothelial nitric-oxide synthase
12. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
13. Interactions between nitric oxide and lipid oxidation pathways: Implications for vascular disease
14. Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide
15. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta
16. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion
17. Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injury
18. -/- mice are ameliorated by enalapril treatment
19. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice
20. Pathology of atheromatous lesions in inbred and genetically engineered mice: Genetic determination of arterial calcification
21. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice
22. Monocyte transmigration induced by modification of low-density lipoprotein in co-cultures of human aortic wall cells is due to induction of monocyte chemotactic protein I synthesis, and is abolished by high density lipoprotein
23. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice
24. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity
25. Nitric oxide: Physiology, pathophysiology, and pharmacology
26. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase free radical-catalyzed mechanism
27. Low density lipoprotein oxidation and its pathobiological significance
28. Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice
29. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase
30. Lessons from genetically engineered animal models IV: Nitric oxide synthase gene knockout mice